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ABSTRACT Antoﬁne, a phenanthroindolizidine alkaloid, is a bioactive natural prod-
uct isolated from milkweeds that exhibits numerous biological activities, including
anticancer, antimicrobial, antiviral, and anti-inﬂammatory properties. However, the
direct targets and mode of action of antoﬁne have not been determined. In this re-
port, we show that antoﬁne displays antifungal properties against the phytopatho-
gen Fusarium graminearum, the cause of Fusarium head blight disease (FHB). FHB
does devastating damage to agriculture, causing billions of dollars in economic
losses annually. We therefore sought to understand the mode of action of antoﬁne
in F. graminearum using insights from yeast chemical genomic screens. We used
haploinsufﬁciency proﬁling (HIP) to identify putative targets of antoﬁne in yeast and
identiﬁed three candidate targets, two of which had homologs in F. graminearum.
The Fusarium homologues of two targets, glutamate dehydrogenase (FgGDH) and
resistance to rapamycin deletion 2 (FgRRD2), can bind antoﬁne. Of the two genes,
only the Fgrrd2 knockout displayed a loss of virulence in wheat, indicating that
RRD2 is an antivirulence target of antoﬁne in F. graminearum. Mechanistically, we
demonstrate that antoﬁne disrupts the interaction between FgRRD2 and FgTap42,
which is part of the Tap42-phosphatase complex in the target of rapamycin (TOR)
signaling pathway, a central regulator of cell growth in eukaryotes and a pathway of
extensive study for controlling numerous pathologies.
IMPORTANCE Fusarium head blight caused by the fungal pathogen Fusarium
graminearum is a devastating disease of cereal crops worldwide, with limited effec-
tive chemical treatments available. Here we show that the natural alkaloid com-
pound antoﬁne can inhibit fusarium head blight in wheat. Using yeast genomic
screening, we identiﬁed the TOR pathway component RRD2 as a target of antoﬁne
that is also required for F. graminearum pathogenicity.
KEYWORDS Fusarium, drug targets, rapamycin
Antoﬁne belongs to the phenanthroindolizidine class of alkaloids that are produced byrelatives of the milkweed family (Apocynaceae subfamily Asclepiadoideae), which in-
clude Vincetoxicum spp., as well as members of the related genus Tylophora (1). These
compounds have received signiﬁcant attention as candidate anticancer agents, which
promote apoptosis in cancer cell lines by inhibiting nuclear factor-kappa B (NF-B) (2).
Antoﬁne has also been shown to suppress DNA and suppress cell cycle arrest as well as
endosomal signaling (3, 4). More recently, the compound has been shown to inhibit
angiogenesis in endothelial cells (5). Speciﬁcally, vascular endothelial growth factor (VEGF),
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which stimulates angiogenesis through the action of protein kinase B or AKT/mTOR
signaling pathways, is inhibited by antoﬁne via an unknown mechanism (5).
Antoﬁne has also been shown to inhibit growth of a variety of microorganisms,
including two strains of the phytopathogen Fusarium graminearum (6), which causes
Fusarium head blight (FHB) disease in small-grain cereals, resulting in low-yield, low-
quality, mycotoxin-contaminated grain, which poses a serious threat to food safety and
the economy (7). Due to the ubiquitous global distribution of F. graminearum, most
agronomic practices aimed at controlling FHB, including chemical control, offer only
moderate control and do not eliminate the proliferation of the disease. Only a few
active ingredients have been registered to suppress F. graminearum as a foliar or seed
treatment in cereals (8). Most of these compounds belong to the triazole group of
fungicides and include tebuconazole, triticonazole, difenoconazole, and ipconazole.
The efﬁcacy of these fungicides can vary between Fusarium species, and moreover,
emergence of fungicide-resistant strains is compelling stakeholders to develop new
strategies to combat FHB disease (9, 10).
Although ubiquitous in eukaryotes, only recently has the TOR signaling pathway
been documented to play a role in F. graminearum development and pathogenesis
(11). Inhibition of TOR signaling by rapamycin, which binds Fkbp12 to inhibit Tor kinase
and the downstream Tap42 protein phosphatase complex, reduces both vegetative
growth and conidial germination, leading to reduced pathogenicity (11). In addition,
two peptidyl-proly cis/trans-isomerases, RRD1 (FGSG_09229) and RRD2 (FGSG_01092),
which regulate the activity of type 2A phosphatases of the TOR pathway and confer
resistance to rapamycin when mutated (12), have overlapping functions in mycotoxin
production and virulence, as well as growth and reproduction (13). However, the
severity of growth defects and asexual spore production are more pronounced in the
F. graminearum rrd2 (Fgrrd2) mutant than Fgrrd1 (13). In addition, FgRRD2, but not
FgRRD1, modulates sensitivity to the phenylpyrrole fungicide ﬂudioxonil and plays a
dominant role in regulation of the high-osmolarity glycerol (HOG) pathway in F.
graminearum (13).
In this report, we use yeast haploinsufﬁciency proﬁling (HIP) to identify potential
targets of antoﬁne. We show that RRD2 is a target of antoﬁne in F. graminearum.
Additionally, we show that binding of antoﬁne to RRD2 leads to the disruption of the
Tap42 phosphatase complex, providing a potential mechanism for disruption of the
TOR signaling pathway.
RESULTS AND DISCUSSION
We puriﬁed antoﬁne from Vincetoxicum to homogeneity as previously described
(see Fig. S1A in the supplemental material) (6). After establishing a standard growth
curve based on spore concentrations (Fig. S1B) and a linear relationship between
mycelial growth and weight (Fig. S1C), we showed that antoﬁne suppressed F.
graminearum germination and growth in a dose-dependent manner with a 50%
inhibitory concentration (IC50) of 100 g/ml (see Fig. S2A in the supplemental ma-
terial). Tylophorine is structurally related to antoﬁne, and both compounds display
similar activities, including growth inhibition of many cancer cell lines by blocking
S-phase transition and arresting HepG2, HONE-1, and NUCG-3 carcinoma cells at the G1
phase (14). However, the suppression of F. graminearum germination and growth (as
well as yeast growth [Fig. 1B]) was speciﬁc to antoﬁne, and we therefore used
tylophorine as a biologically inactive negative control (Fig. 1A) (15). In addition to
suppressing in vitro growth, antoﬁne decreased FHB symptoms on wheat heads when
coinoculated with F. graminearum spores (Fig. S2B). It should be noted that at the
antoﬁne concentrations tested, antoﬁne alone did not produce any observable dele-
terious effects such as kernel weight (data not shown).
In order to identify potential targets of antoﬁne, we used haploinsufﬁciency proﬁling
(HIP) in yeast (16). HIP exploits drug-induced haploinsufﬁciency, as measured by growth
defects resulting from deletion of one copy of a drug target gene, and has been used
to identify the targets of small molecules, including fungicides (16). After establishing
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a sublethal concentration (2 g/ml) of antoﬁne (see Fig. S3A in the supplemental
material), we conducted an HIP screen on 6,000 yeast heterozygous strains and
identiﬁed three heterozygous strains that were hypersensitive to antoﬁne. While wild-
type (WT) yeast growth was inhibited by 2.5% at 2.0 g/ml of antoﬁne (4 M), the 3
heterozygous mutants YOR375C, YBR095C, and YIL153W displayed 23, 15.5, and 12.5%
growth inhibition, respectively (Fig. S3B). The Saccharomyces cerevisiae glutamate
dehydrogenase gene (ScGDH1; YOR375C) has a homologue in F. graminearum
(FGSG_07174) with 73% identity, and the ScRRD1 gene (resistant to rapamycin deletion
1; YIL153W) has two homologues in F. graminearum, FGSG_09229 (FgRRD1) and
FGSG_01092 (FgRRD2), with identities of 38 and 32%, respectively (13). The third target
identiﬁed in yeast YBR095C showed a weak homology (18% identity) with F.
graminearum gene FGSG_08612, and the homology between these proteins was not
contiguous. Therefore, we pursued FgGDH1, FgRRD1, and FgRRD2 for further charac-
terization as putative targets of antoﬁne. Note that both Scgdh1 and Scrrd1 mutant
strains displayed no hypersensitivity to the negative-control tylophorine (Fig. 1B).
To determine if F. graminearum genes could complement yeast mutants, we ex-
FIG 1 Antoﬁne inhibits growth of F. graminearum and targets GDH1 and RRD1. (A). Wild-type F. graminearum (Fg) spores were coincubated with 100 g/ml
of antoﬁne (A100), tylophorine (T100), or solvent control (), and mycelial growth was monitored by absorbance at 600 nm (ABS600). Results are representative
of ﬁve biological replicates. The chemical structures of tylophorine and antoﬁne are shown. (B) Growth of wild-type S. cerevisiae (Sc WT) or Scgdh1 and Scrrd1
mutants in the presence of 2 g/ml antoﬁne (A2), tylophorine (T2), or solvent control () was monitored by absorbance at 600 nm (ABS600). Values represent
the average of three technical replicates with standard deviation. The results are representative of four biological replicates. (C) F. graminearum GDH1 and RRD2
complement antoﬁne hypersensitivity to the Scgdh1 and Scrrd1mutants, respectively. Fg GDH1 (FGSG_07174) was expressed in the Scgdh1mutant, and FgRRD1
(FGSG_09229) and FgRRD2 (FGSG_01092) were expressed in the S. cerevisiae Scrrd1 mutant. Empty vectors (EVs) were used as controls. Expression of FgGDH1
and FgRRD1 was induced by galactose and was monitored in the absence and presence of 2 g/ml antoﬁne. Values represent average percentage of growth
with respect to growth in the absence of antoﬁne of three technical replicates with standard deviation. (D) Thermal shift assays using 1 mg/ml of puriﬁed
FgGDH1 and FgRRD2 proteins in the absence and presence of antoﬁne (A100), and tylophorine (T100) at 100 g/ml. Results are representative of two independent
biological replicates with four technical replicates in each experiment.
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pressed FgRRD1 (FGSG_09229) and FgRRD2 (FGSG_01092) in the S. cerevisiae YIL153
mutant strain and expressed FgGDH1 (FGSG_07174) in the S. cerevisiae YOR375C
mutant strain. FgGDH1 was able to partially complement the antoﬁne sensitivity of the
Scgdh1 mutant strain (Fig. 1C). Interestingly, FgRRD2 (P  0.01) but not FgRRD1 was
able to partially rescue antoﬁne sensitivity in the Scrrd1mutant strain and was therefore
chosen for further analysis (Fig. 1C). To test if FgGDH1 and FgRRD2 are direct targets of
antoﬁne, both genes were cloned and expressed, and the puriﬁed protein (see Fig. S4
in the supplemental material) was used in thermal shift assays (TSAs) (17, 18). TSA
determines a shift in the melting temperature (Tm) of a protein upon binding to a
ligand, measured by changes in light scattering or ﬂuorescence. The Tm of FgGDH
shifted from 61°C to 62.4°C in the presence of 100 g/ml of antoﬁne (Fig. 1D; A100);
however, in the presence of 100 g/ml of tylophorine, the Tm did not shift relative to
FgGDH alone (Fig. 1D; T100). The TSA also showed that the Tm of puriﬁed FgRRD2 shifted
from 51°C to 54°C (Fig. 1D; A100) and similar to FgGDH, the shift with tylophorine was
negligible compared to that with the protein alone (Fig. 1D; T100). The TSA results
indicate that antoﬁne binds both FgGDH and FgRRD2 proteins.
Since antoﬁne inhibited FHB symptoms on wheat (Fig. S2B), we tested whether both
antoﬁne targets were associated with fusarium pathogenicity. We deleted GDH1 and RRD2
in F. graminearum and performed pathology tests on the susceptible wheat variety Roblin.
The deletion of FgGDH1 did not affect the pathogenicity, suggesting that it is not the
antoﬁne target responsible for F. graminearum virulence (see Fig. S5A in the supplemental
material). In contrast, targeted deletion of FgRRD2 signiﬁcantly affected the virulence of F.
graminearum (Fig. S5B). After 15 days postinfection (dpi), the entire wheat head was
bleached after inoculation with wild-type F. graminearum spores (Fig. S5B; Fg), while no
such effect was visible after inoculation with the mutant strain (Fig. S5B; Fg rrd2). It is likely
that growth defects and its inability to produce the mycotoxin deoxynivalenol signiﬁcantly
contributes to the virulence defects (13). Overexpression of FgRRD2 in the Fgrrd2 mutant
strain (Fgrrd1::OEFgRRD2) not only restored F. graminearum virulence (Fig. S5b; Fg rrd2:OEFg
RRD2) but also counteracted the effect of antoﬁne (Fig. 2C). These results suggest that
although antoﬁne appears to have multiple targets, FgRRD2 is the target responsible for
virulence inhibition in F. graminearum (13).
The haploid yeast rrd1 mutant and mutants of the two homologues in the F.
graminearum strain PH1, Fgrrd1 and Fgrrd2, have been shown to be resistant to the
inhibitory effects of rapamycin (12, 13). We conﬁrmed this phenotype for the Fgrrd2
mutant in our F. graminearum strain (DAOM 233423 [Fig. 2]). Wild-type F. graminearum
spores pretreated with rapamycin at 10 and 20 ng/ml decreased in growth by 50 and
80%, respectively, relative to untreated spores (Fig. 2A; Fg Wt). However, no such
growth inhibition was observed with the Fgrrd2 mutant strain exposed to rapamycin
(Fig. 2A; Fg rrd2). We therefore hypothesized that if antoﬁne antagonizes RRD2, it
should chemically phenocopy the rapamycin insensitivity of the Fgrrd2 mutant. In
support of this, growth of wild-type F. graminearum spores was monitored in the
presence of sublethal doses of antoﬁne (50 and 100 g/ml [A50 and A100, respectively])
and inhibitory concentrations of rapamycin (20 and 50 ng/ml [R20 and R50, respec-
tively]) (Fig. 2B). We observed that the inhibitory effects of rapamycin at both doses
were suppressed by antoﬁne at 50 g/ml (Fig. 2B). Antoﬁne at 100 g/ml suppressed
the inhibitory effect of rapamycin at the lower concentration (20 ng/ml) but not at the
higher concentration (50 ng/ml), likely due to synergism between antoﬁne and rapa-
mycin toxicity at higher concentrations. Altogether, the results strongly support RRD2
as a direct target of antoﬁne.
RRD is a component of the target of the rapamycin signaling pathway, which is
evolutionarily conserved and important for cell growth in eukaryotes (19). In yeast, the
rapamycin-sensitive Tor complex 1 (TORC1), in addition to promoting anabolic pro-
cesses, leads to suppression of stress response pathways (20). This dual role makes this
pathway an extremely important subject area of study since its disruption either
through mutation or through chemical inhibition can inﬂuence numerous diseases,
including cancer and diabetes (21). TORC1 mediates these pathways through regula-
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tion of a set of serine/threonine protein phosphatases, including Sit4, protein phos-
phatase 2A (PP2A), and Ppg1, which together form the phosphatase-associating pro-
tein Tap42 protein complex in a nutrient- and Tor-dependent manner (22). The current
model suggests that TORC1 is associated with the Tap42-phosphatase complexes, and
upon nutrient stress or rapamycin treatment, the Tap42-phosphatase complex is
released from TORC1 (22). This event disassembles the Tap42-phosphatase complex,
leading to the activation of the phosphatases and inhibition of Tor activity (19).
Therefore, as a positive regulator of phosphatases, Tap42 represents an important
regulator of the TOR signaling pathway.
In F. graminearum, the interactions between components of the Tap42-phosphatase
complex have been demonstrated (11, 13). Speciﬁcally, FGSG_09800 (Tap42) interacts
with the phosphatases Sit4 (FGSG_01464), Ppg1 (FGSG_05281), and Pp2A (FGSG_
09815), protein phosphatase activators RRD1 (FGSG_09229) and RRD2 (FGSG_01092),
and a Tap42 interactor protein, Tip41 (FGSG_06963) (Fig. 3A) (11, 13). Mutation of the
phosphatases Sit4 and Ppg1, the Tap42 interactor Tip41, or the phosphatase activators
RRD1 and RRD2 leads to reduction of virulence of F. graminearum (11, 13). Since
antoﬁne appears to target RRD2 (FGSG_01092), we tested whether its interactions with
Tap42 complex proteins are disrupted by antoﬁne. We performed yeast two-hybrid
(Y2H) analysis between FgRRD2 and FgTap42, FgSit4, FgPpg1, FgPp2A, and FgTip41 and
found that FgRRD2 interacted only with FgTap42 (see Fig. S6A in the supplemental
material). To validate these ﬁndings, we quantitatively assessed the interaction between
FgTap42 and FgRRD2 by ONPG (o-nitrophenyl--D-galactopyranoside) assay (Fig. 3B) (23).
FIG 2 Antoﬁne phenocopies the rrd2 mutation in F. graminearum by suppressing rapamycin toxicity. (A) Growth
of the F. graminearum RRD2 mutant (Fgrrd2) is insensitive to rapamycin inhibition. Growth inhibition of wild-type
(Fg Wt) or RRD2 mutant (Fg rrd2) F. graminearum spores coincubated with 10 and 20 ng/ml of rapamycin was
monitored by absorbance at 600 nm (ABS600). (B) Growth inhibition of wild-type F. graminearum by rapamycin is
suppressed by antoﬁne (A50 and A100). Growth (optical density at 600 nm [OD600]) of wild-type F. graminearum
spores was monitored in the presence of rapamycin at concentrations of 20 or 50 ng/ml (R20 and R50) alone or in
combination with 50 or 100 g/ml of antoﬁne (A50 and A100). (C) Overexpression of RRD2 suppresses antoﬁne
toxicity. The mycelial growth of wild-type (Fg), FgRRD2 mutant (Fg rrd2), and overexpressor of RRD2 (Fg rrd2:OEFg
RRD2) F. graminearum strains was monitored by absorbance at 600 nm (ABS600) in the absence () and in the
presence of 50 and 100 ng/ml of antoﬁne (A50 and A100). Values represent the average from three technical
replicates with standard deviation. Results are representative of four independent biological replicates.
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The strong interaction between Tap42 and RRD2 was inhibited even at a very low
concentration of antoﬁne (0.1g/ml [Fig. 3B]), while another interaction between Tap42
and Ppg1 remained intact even at higher concentrations of antoﬁne (1g/ml [Fig. 3C]).
Inhibition of the FgTap42-FgRRD2 interaction was relatively speciﬁc to antoﬁne (P 0.0002)
since inhibition with tylophorine was weak and only signiﬁcant at the higher concentration
tested (1g/ml [Fig. 3A]). Finally, we showed that antoﬁne treatment was not deleterious
to the accumulation of FgRRD2, FgTap42, and FgPpg1 proteins (Fig. S6B). Since RRD binds
to Tap42, we hypothesize that disruption of interaction between FgRRD2 and Tap42 by
antoﬁne may deregulate the disassembly process of the Tap42-phosphatase complex with
TORC1, potentially affecting Tor activation.
In summary, we have identiﬁed targets of antoﬁne in F. graminearum, one of which
(RRD2) is crucial for pathogenicity in wheat. Our ﬁnding that the plant-derived com-
pound antoﬁne directly impacts the action of TOR signaling provides an additional tool
to dissect this complex signaling pathway and a potential lead compound for integra-
tive pest management programs in crop protection. In addition to rapamycin, other
FIG 3 Antoﬁne targets RRD2 and disrupts the Tap42-phosphatase complex in F. graminearum. (A) Model representing the TOR complex
with components of the Tap42-phosphatase complex highlighting the negative regulation of RRD2 by antoﬁne. The phosphatases are
colored green. (B) Antoﬁne speciﬁcally disrupts FgTap42-FgRRD2 protein interaction in the Tap42 complex. The gene pairs FgTap42 and
FgRRD2 and FgTap42 andFgPpg1 were expressed in yeast in the absence () and in the presence of antoﬁne and tylophorine at 0.1 and
1 g/ml. The -galactosidase speciﬁc activity (in Miller units) was measured by the ONPG assay (23). (C) The interaction between Tap42
and FgPpg1 has been demonstrated previously and was used as a positive control (11). Shown is a representative of three independent
biological replicates, each with three technical replicates.
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inhibitors of the TOR pathway such as PP242, which acts as a competitive inhibitor for
the ATP binding site of mammalian TOR, have been proposed for therapeutic use (24).
More recently, PP242 was also used to inhibit the plant Tor kinase and reduce F.
graminearum disease development in Arabidopsis (25). A similar increase in resistance
to pathogens was observed when signaling from the TOR pathway was attenuated in
Arabidopsis with a mutation in the Raptor gene, a direct target of the Tor kinase (26).
However, the same study showed that manipulation of the TOR pathway could have
unintended negative effects on plant growth, which presents an obvious hurdle to
targeting this pathway for crop protection.
Large-scale fungicide use in agriculture is leading to emergence of multidrug
resistance (MDR) in fungal strains, characterized by partial to complete resistance to
fungicides (10). In this context, combinatorial drug application is one approach that can
be used to combat MDR pathogens in agriculture. Such an approach is common in
treating human diseases such as HIV and malaria and is also a strategy to combat
deadly human fungal pathogens, such as Candida, Aspergillus, and Cryptococcus, and
block the emergence of resistance (27, 28). The latter study showed that the small
molecule beauvericin increased efﬁcacy of azole-derived compounds through the
inhibition of a multidrug efﬂux pump and the TOR signaling pathway (28). Similarly, a
checkerboard analysis between antoﬁne and existing fungicides could reveal concen-
trations of antoﬁne that are benign to humans but can increase the efﬁcacy of other
commonly used azole-derived fungicides used in agriculture (29).
MATERIALS AND METHODS
Puriﬁcation and conﬁrmation by NMR of antoﬁne. Root tissues of Vincetoxium rossicum were
harvested, vacuum desiccated, and crushed in EtOAc. The crude extract was ﬁltered, concentrated by
rotary evaporator, and dissolved in 0.01 M HCl. The pH was reduced to 2.0 with 1 M HCl and the solution
partitioned with EtOAc. The organic fraction was concentrated by rotary evaporator and dried for
storage. The pH of the aqueous fraction was increased to 10 with 1 M NH4OH and partitioned with EtOAc.
The alkaline fraction containing antoﬁne was concentrated by rotary evaporator, dissolved in pure
acetonitrile (ACN), and injected into a 250- by 10-mm 5-m 120-Å C18 reverse-phase semipreparatory
column (ACE-121-2510; Advanced Chromatography Technologies). The column was preequilibrated in a
gradient (5% ACN in water to 75% ACN in water) over 20 min at 10 ml/min. Antoﬁne was eluted in 75%
ACN–distilled water (dH2O) in 10-ml fractions for 20 min. An aliquot of 2 ml from each sample was dried
using a SpeedVac (SVC-100H; Savant) and suspended in 200 l methanol (MeOH). A 10-l aliquot was
spotted onto a sterile 6-mm ﬁlter disc. The discs were placed amended side down on petri dishes
containing 2% YPD (yeast extract-peptone-dextrose) agar evenly spread with 1.0 106 CFU of S.
cerevisiae BY4741 and incubated at 30°C overnight. The fractions that demonstrated an inhibition zone
were pooled and dried using a rotary evaporator. The pellet was suspended in MeOH and spotted onto
a glass-backed silica thin-layer chromatography (TLC) plate (5715-7; EMD Chemicals). Compounds were
separated by TLC with two consecutive migrations of 60:40 EtOAc-MeOH and traced by illumination
under shortwave (254-nm) UV light. Each band was scraped from the silica plate and recovered using
MeOH. The MeOH was removed by rotary evaporator, and the recovered compounds were solubilized in
CHCl3 and tested for activity as described before. Puriﬁed antoﬁne was subjected to 1H nuclear magnetic
resonance (NMR) for conﬁrmation. The NMR spectrum was recorded on a Bruker Avance 400-MHz NMR
spectrometer. The sample was recorded using CDCl3 as the solvent, purchased from Cambridge Isotope
Laboratories, Inc. The reference peak was set using the known residual solvent peak of CDCl3 at 7.26
ppm. The NMR spectrum was compared to the known spectrum of antoﬁne (30).
Identiﬁcation of antoﬁne targets in yeast by haploinsufﬁciency proﬁling. The Yeast Heterozy-
gous Knock-Out collection (Open Biosystems; GE Healthcare, USA), along with the diploid wild-type strain
(BY4743), was copied to solid 2% YPD agar amended with 150 g/ml G418, contained in an Omniwell
plate (Nunc catalog no. 242811), using a 96-pin replicator (Nunc catalog no. 250520) and the OmniTray
copier (Nunc catalog no. 250555) and incubated overnight at 30°C. The initial screen was initiated with
antoﬁne (0.75 g/ml) and incubated for 24 h at 30°C. The plates were scanned as a grayscale image
(Epson Perfection V750 Pro) and processed with the Epson Scan version 3.24A scanning software at a
300-dpi resolution. The initial screen was repeated 6 times at antoﬁne concentrations of 2.75, 2.5, 2.0, and
1.25 g/ml, with a ﬁnal concentration of methanol at 0.01%. The results of the initial screens were
analyzed together using the Screen Mill analysis package, and all mutants that received a P value of
0.05 were selected for further analysis (31).
Our initial screen yielded 873 potential candidates. To further narrow the list of candidates, we
employed a liquid-based analysis. Brieﬂy, each mutant was grown to an absorbance at 600 nm (ABS600)
of 5.0, and 10 l of this new cell suspension was transferred to a new 96-well plate containing 190 l
of YPD and bringing the cell density equivalent to an ABS600 reading of 0.25 (5.0 106 CFU/ml),
supplemented with 0.20 g/ml of Antoﬁne. The plate was then loaded into a BioTek Powerwave plate
reader, for incubation at 30°C, and then the growth was assessed by ABS600 every 10 min over the course
of 48 h. The growth for each mutant (with antoﬁne) was then compared to the average growth
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calculated for the WT (with antoﬁne), by subtracting the calculated percentage of WT growth from the
calculated percentage of growth for the mutant, where a positive result signiﬁed the mutant grew better
than the WT under experimental conditions, and a negative result signiﬁed the mutant grew poorer than
the WT when antoﬁne was present. We used 10% as the cutoff for growth differences. This analysis
yielded 16 mutants sensitive to antoﬁne.
To conﬁrm the observed effect of antoﬁne, 16 antoﬁne-sensitive mutants were further screened with
three concentrations of antoﬁne (2.5, 2, and 1.5 g/ml) in triplicate. This was repeated three times. After
analysis, three yeast mutants (YBR095C, YOR375C, and YIL153W) showed a consistent sensitive pheno-
type to antoﬁne.
ScreenMill analysis. The differences in colony growth were assessed by the ScreenMill growth
measurement and analysis software suite (31). Brieﬂy, each plate is scanned and then analyzed using the
colony measurement engine, which detects each colony and assigns each a numerical value based upon
its circularity and size. The ﬁle output is then input into the data review engine. A web-based application
normalizes raw screen data and provides the user with an opportunity to manually select data for
exclusion from analysis. The normalized data are used to calculate P values by t test for parametric data
or the Mann-Whitney test for nonparametric data.
Construction of F. graminearum Fggdh1 and Fgrrd2 mutant strains and the Fgrrd2::OEFgRRD2
overexpression strain. F. graminearum wild-type strain DAOM 233423 (NRRL29169) was provided by C.
Babcock of the Canadian Collection of Fungal Cultures (CCFC/DAOM), Agriculture and Agri-Food Canada,
Ottawa. Macroconidia were used as the inoculum for all experiments and were produced in a liquid
carboxymethyl cellulose medium (32). All of the plasmids were constructed by the USER (uracil-speciﬁc
excision reagent) technique and outlined (see Fig. S7 in the supplemental material) (33). The deletion of
FgGDH (FGSG_07174) and FgRRD2 (FGSG_01092) was performed by PCR ampliﬁcation of the two
homologous recombination sequences (HRSs) for each gene. HRS1 for FGSG_07174 was obtained with
primer sets Fg 07174 USER Up-F/R, and HRS1 for FGSG_01092 was obtained with Fg 01092 USER Up-F/R.
HRS2 for FGSG_07174 was obtained with primer sets Fg 07174 USER Dn-F/R, and HRS2 for FGSG_01092
was obtained with Fg 01092 USER Dn-F/R. PCR products HRS1 and HRS2 were introduced into the
pRF-HU2 vector with hygromycin (Hyg) as the selection marker. The Fgrrd2::OEFgRRD2 overexpression
strain was constructed by introducing FGSG_01092 cDNA into the pRF-GUE vector with Geneticin as the
selection marker (Gen). The cDNA was ampliﬁed by the primer set Fg 01092 GUE_F/R. The F.
graminearum mutants were screened for the presence and absence of FGSG_07174 and FGSG_01092
with primer sets Fg 07174 Orf F/R and Fg 01092 Orf F/R, respectively. The presence of the gpdA promoter
in the Fgrrd1::OEFg RRD1strain was conﬁrmed by the primer set Gpd Pro F and Fg 01092 Orf R. The
sequences of the primers are listed in Table S1 in the supplemental material. Touchdown PCR conditions
were used to conﬁrm F. graminearum transgenic strains: 100 ng of genomic DNA for 8 cycles at 63 to 55°C
and for 22 cycles at 55°C. We veriﬁed the copy number in the mutant strains by quantitative real-time
PCR (qRT-PCR) analyses (Fig. S7G). Brieﬂy, the analyses were performed with the primer set Fg 01092
qPCR F/R for FGSG_01092 and the primer set Fg 07174 F/R for FGSG_07174 and normalized with a known
single-copy gene coding for glyceraldehyde-3-phosphate dehydrogenase, GAPDH (FGSG_16627), using
the primer set Fg 16627 F/R (Table S1) (34). All samples were assessed in triplicate using the QuantStu-
dio3 (Applied Biosystems, USA).
RNA extraction and cDNA library from F. graminearum. F. graminearum strains were grown in a
mixture of 56 mM NH4Cl, 8.1 mM MgSO4·7H2O, 0.23 mM FeSO4·7H2O, 14.7 mM KH2PO4, 2 g/liter peptone,
2 g/liter yeast extract, 2 g/liter malt extract, and 111 mM glucose for 24 h, and total RNA was extracted
from mycelia using TRIzol reagent (Invitrogen), puriﬁed using the InviTrap Spin cell RNA minikit (Stratec,
Germany), and then converted into cDNA (1 g) using the Applied Biosystems high-capacity cDNA
reverse transcription kit. RT-PCRs were similar to the touchdown PCR conditions mentioned before.
Growth curve assays with inhibitors. One thousand spores from F. graminearum wild-type (Wt),
ΔFGSG 07174 and ΔFGSG 01092 mutant strains, and the Fgrrd2::OEFgRRD2strain were inoculated in 200
l GYEP medium (0.1% KH2PO4, 0.05% MgSO4·7H20, 0.05% KCl, 0.02% [vol/vol] trace element solution,
and 0.01% sucrose). The spore germination assay was set up in 96-well microtiter plates (Corning 3632),
and growth was monitored over a 48-h period at 600 nm using the FLUOstar Optima plate reader (BMG
Labtech, USA) in a ﬁnal volume of 200 l. We assessed the germination and growth of various numbers
of spores (250, 500, and 1,000) by absorbance (  600 nm) and visualization at numerous time points
with a Zeiss AxioImager M2 microscope (Carl Zeiss Canada, Toronto, Ontario) (Fig. S1B). An absorbance
reading of 0.5 was the same for all the spore concentrations at 48 h. Therefore, we used 48 h as the
endpoint measurement for all of the fusarium spore germination/growth assays. All yeast strains were
grown overnight in YPD (yeast extract-peptone-dextrose) at 30°C with shaking at 200 rpm overnight.
Cells were diluted to an ABS600 of 0.5 and used in growth curve assays. The growth was monitored over
a 24-h period at 600 nm using the FLUOstar Optima plate reader as described before. The inhibitors were
dissolved in 100% methanol and were used at the indicated concentrations in a 1% ﬁnal concentration
of methanol in all of the liquid assays.
Puriﬁcation of FgGDH (FGSG_07174) and FgRRD1 (FGSG_01092) from yeast. Both FGSG_07174
and FGSG_01092 were cloned into the pYES-DEST 52 Gateway destination plasmid vector by LR clonase
reaction (Life Technology, USA). Plasmids were transformed into yeast knockout strains YOR375C and
YIL153W, respectively. The complemented yeast was grown in 5 ml of Sabouraud dextrose (SD) medium
lacking uracil in the presence of 2% glucose and antibiotic selection with G418 (Sigma) overnight at 30°C.
Yeast cells were transferred in a 1:100 ratio to 30 ml of inducing medium with 2% galactose, 1% rafﬁnose,
and G418 overnight at 30°C. Yeast cells then were harvested by centrifugation at 2,700  g for 10 min.
The resulting yeast pellet was processed for protein extraction. The His-tagged proteins were puriﬁed
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using the Clontech His-tagged puriﬁcation miniprep kit. Yeast pellet containing the His-tagged protein
was thawed in 1 ml X-tractor buffer, 100 l Zymolyase (5 U/l; G Biosciences), 40 l of 25 Roche
Complete mini-protease inhibitor cocktail, 10 l RNase A (20 mg/ml; Sigma), and 5 l DNase I (10 U/l;
Agilent). The lysate was incubated at 37°C for 1 h and puriﬁed according to the manufacturer’s
instructions with modiﬁcations. Brieﬂy, the total lysates were centrifuged at 15,000 rpm to get rid of the
cellular debris, and the supernatant was loaded onto the afﬁnity column. After washes with buffer
(20 mM Tris [pH 8.0], 30 mM NaCl, 2 mM dithiothreitol [DTT], and protease inhibitor cocktail) containing
20 and 50 mM imidazole, proteins were eluted with buffer containing 500 mM imidazole. Eluates were
dialyzed with buffer overnight at 4°C. Glycerol was added to a ﬁnal concentration of 20%, and the
mixture was stored at 20°C until use.
TSAs. Thermal shift assays (TSAs) were performed with puriﬁed FgGDH and FgRRD2 proteins. The TSA
was performed in Quant Studio 3 (Applied Biosystems) with the Applied Biosystems protein thermal shift
dye kit (4461146) in a 20-l reaction volume containing 1 mg/ml of each protein with or without antoﬁne
or tylophorine (Santa Cruz Biotechnologies, USA) at 100 g/ml (0.1% methanol). The PCR conditions were
used according to the manufacturer’s instructions, and data were analyzed with Protein Thermal Shift
software version 1.3 (Thermo Fisher Scientiﬁc). Melting temperature (Tm) data were generated using the
Boltzmann method. ΔTm was calculated by comparing the Tm values for each protein without the
inhibitors to those with the inhibitors. Data were collected at 1°C intervals from 25°C through 99°C and
are shown in the replicate result plot view of the Protein Thermal Shift software.
Fusarium infection assay. Each strain was assessed for the ability to infect susceptible Triticum
aestivum (cv. Roblin). Wheat heads (10 heads per strain) were point inoculated at mid-anthesis with each
strain at 100,000 spores/ml in a volume of 10 l (1,000 spores). Spores were inoculated between the
palea and lemma of a single wheat spikelet. Plants were grown at 25°C for 16-h days with misting every
hour for 30 s. After 48 h, misting was reduced to a duration of 30 s every 4 h. Infection was scored by
counting the number of visibly infected spikelets at days 5, 10, and 15 (32).
Yeast two-hybrid and ONPG assays. The coding sequences of FgTap42, FgRRD2, FgTip41, FgPp2A,
and FgPpg1 from F. graminearum were synthesized and cloned into the pDONR vector (General
Biosystems, Morrisville, NC). The genes were subcloned into the yeast vectors pJG4-5 (activation domain
B42) and pEG202 (DNA binding domain LexA) by Gateway LR Clonase II reaction (Thermo Fisher
Scientiﬁc). Yeast two-hybrid plasmid pairs were transformed into S. cerevisiae strains RFY206 and EGY48,
before mating and selection on synthetic medium lacking histidine, uracil, and tryptophan. Two
independent yeast colonies containing both pJG4-5 and pEG202 for each gene pair were selected for
interaction, and the interaction was quantiﬁed by a -galactosidase activity assay with ONPG (23).
Interaction was monitored in the presence of either antoﬁne or tylophorine (0, 0.1, and 1 g/ml). Three
independent experiments were performed, using corresponding empty vectors as negative controls. All
the yeast strains were grown as described before in the puriﬁcation of FgGDH1 and FgRRD1, except the
induction with galactose was limited to 1 h. To ensure that expressed proteins were not affected by
antoﬁne, extracts from noninduced and induced cultures (antoﬁne or tylophorine) were subjected to
Western blot analyses. Proteins were extracted by 2 M LiAc and 0.4 M NaOH followed by boiling in
Laemmli buffer. Twenty micrograms of protein from each sample was separated on a 10% SDS-PAGE gel,
and the blots were probed with LexA antibodies for detection of FgTap42 (Millipore Sigma, USA) and
hemagglutinin (HA) antibodies (Roche, Germany) to detect both FgRRD2 and FgPpg1 proteins. Proteins
were detected by the ECL enhanced chemiluminescence substrate (Lumigen ECL Ultra; TMA-6).
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